Announcement: ERS releases statement on the Philips recall notice

Announcement: ERS releases statement on the Philips recall notice - article image

The European Respiratory Society (ERS) has released a statement on the Field Safety Notification issued by Philips Respironics on 14 June, 2021, which reports the potential risk of a number of positive airway pressure (PAP) devices used for treatment of sleep apnoea and respiratory failure.

According to the manufacturer, the polyester-based polyurethane foam used in their devices may degrade into particles and volatile gas products, which the user may inhale. This may result in potential health risks for the user, including local airway irritation.

The statement provides recommendations for respiratory, sleep and critical care medicine professionals and patients, and is signed by ERS President Anita Simonds, ERS officers from the Sleep Disordered Breathing Assembly and the European Lung Foundation Sleep Patient Advisory Group, with the endorsement of the European Sleep Research Society.

Read the statement

News
Sleep and breathing disorders